Preoperative Biliary Drainage in Resectable Pancreatic or Periampullary Cancer
Completed · Not applicable
Conditions studied: Pancreatic Carcinoma
In brief
The purpose of this study is to demonstrate that preoperative biliary drainage using self-expanding metal stents (SEMS) does not negatively impact overall surgical outcomes in patients undergoing pancreaticoduodenectomy for treatment of pancreatic or periampullary cancer.
Key facts
- Study ID
- NCT01774019
- Run by
- Boston Scientific Corporation
- People needed
- 284
- Starts
- 2013-02-20
- Expected to finish
- 2021-12-13
- Last updated by the study team
- 2023-04-10
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age 18 or older
- Willing and able to comply with the study procedures and provide written informed consent to participate in the study
- Diagnosis of probable pancreatic cancer, distal common bile duct (CBD) cholangiocarcinoma and other periampullary cancers (histology not required)
- Biliary obstructive symptoms or signs
- Bilirubin level at/above 100 umol per liter (5.8 mg/dL)
- Distal biliary obstruction consistent with pancreatic cancer, distal CBD cholangiocarcinoma or other periampullary malignancy
- Location of distal biliary obstruction is such that it would allow the proximal end of a stent to be positioned at least 2cm from the hilum
- Patients deemed as resectable by pancreatic protocol CT or MRI
- Surgical candidate per pancreatobiliary surgeon after multi-disciplinary discussion
- Surgery intent within 4 weeks
- Endoscopic and surgical treatment to be provided by same team
You may not qualify if…
- Biliary strictures caused by confirmed benign tumors
- Biliary strictures caused by malignancies other than pancreatic cancer, distal CBD cholangiocarcinoma and other periampullary cancers
- Surgically altered biliary tract anatomy, not including prior cholecystectomy
- Neoadjuvant chemotherapy for current malignancy
- Palliative indication due to reasons other than surgical candidate status
- Previous biliary drainage by ERCP/PTC
- Patients for whom endoscopic techniques are contraindicated
- Participation in another investigational trial within 90 days
- Pregnancy
Where it is running
- Standford University Medical Center — Stanford, California, United States
- Westmead Hospital — Westmead, New South Wales, Australia
- ULB Erasme Hospital — Brussels, Belgium
- Beijing Friendship Hospital — Beijing, China
- Xijing Hospital of Digestive Diseases Fourth Military Medical University — Xi'an, China
- Hopital Edouard Herriot — Lyon, France
- Queen Elizabeth Hospital — Kowloon, Hong Kong
- Prince of Wales Hospital, the Chinese University of Hong Kong — Shatin, Hong Kong
- Asian Institute of Gastroenterology — Hyderabad, India
- Fondazione Policlinico Universitario Agostino Gemelli — Rome, Italy
- Tokyo Medical University — Tokyo, Japan
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.